Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Elos Medtech in connection with the public offer from TA Associates
Mandate

Vinge advises Elos Medtech in connection with the public offer from TA Associates

June 11, 2021 Capital Markets and Public M&A

TA Associates has announced a public offer to the shareholders of Elos Medtech AB (publ). The total value of the offer is SEK 1,735 million.

Vinge advises Elos Medtech. The Vinge team includes Erik Sjöman, Wibeke Sorling and Johanne Örnfeldt Svensson.

Related

Vinge has advised Oncopeptides in connection with a directed share issue

 Vinge has advised Oncopeptides in connection with a directed share issue, whereby Oncopeptides raises proceeds of SEK 100 million.
October 16, 2026

Vinge advises KGAL on its divestment of a Nordic wind portfolio to Enordic Evergreen

 Vinge has advised KGAL on the divestment of a Nordic onshore wind portfolio to Enordic Evergreen.
October 14, 2026

Vinge has advised Orexo in connection with its rights issue

 Vinge has advised Orexo AB (publ) in connection with a partially guaranteed rights issue of approximately SEK 250 million before transaction costs, subject to approval by an extraordinary general meeting.
October 09, 2026